Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)
Nurix Therapeutics' (NRIX) Asset Utilization Ratio came in at 0.81 for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 439.9% from 0.15 a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Asset Utilization Ratio stood at 0.12, up 16.2% from FY2024.
- In prior fiscal years, Nurix Therapeutics' Asset Utilization Ratio was 0.11 in FY2024 (-46.6%), 0.20 in FY2023 (+130.6%), 0.09 in FY2022 (+26.9%) and 0.07 in FY2021 (-15.8%).
- The fiscal Q3 2026 figure stands as the highest quarterly Asset Utilization Ratio in data going back to fiscal Q4 2020.
- On a year-over-year basis, Asset Utilization Ratio increased in four of the last eight quarters, with growth averaging 45.7%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was fiscal Q3 2026, with growth of 439.9%; the weakest was fiscal Q1 2025, with a decline of 63.7%.
- According to Business Quant data, Asset Utilization Ratio for the three prior fiscal quarters was 0.06 (Q2 2026), 0.11 (Q1 2026) and 0.14 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 0.81 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 0.81 |
| May 31, 2026 | 0.06 |
| Feb 28, 2026 | 0.11 |
| Nov 30, 2025 | 0.14 |
| Aug 31, 2025 | 0.15 |
| May 31, 2025 | 0.15 |
| Feb 28, 2025 | 0.09 |
| Nov 30, 2024 | 0.09 |
| Aug 31, 2024 | 0.11 |
| May 31, 2024 | 0.15 |
| Feb 29, 2024 | 0.24 |
| Nov 30, 2023 | 0.23 |
| Aug 31, 2023 | 0.21 |
| May 31, 2023 | 0.17 |
| Feb 28, 2023 | 0.11 |
| Nov 30, 2022 | 0.09 |
| Aug 31, 2022 | 0.09 |
| May 31, 2022 | 0.09 |
| Feb 28, 2022 | 0.08 |
| Nov 30, 2021 | 0.06 |
API Access
Nurix Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();